Business Context and Reporting Period
Omega Healthcare Investors, Inc. is a healthcare real estate investment trust focused primarily on skilled nursing facilities, assisted living facilities and related healthcare assets in the U.S. and U.K. The company operates as a single reportable segment and uses a long-term lease, mortgage lending and operator-financing model. This unaudited Form 10-Q covers the quarter and nine months ended September 30, 2023, compared with the corresponding 2022 periods.
At September 30, 2023, the portfolio included 913 healthcare facilities in 42 states and the U.K., operated by 70 third-party operators. Approximately 97% of real estate investments related to long-term healthcare facilities.
Key Financial Metrics
| Metric | Q3 2023 | Q3 2022 | 9M 2023 | 9M 2022 |
|---|---|---|---|---|
| Total revenues | $242.0 million | $239.4 million | $710.4 million | $733.4 million |
| Net income | $93.9 million | $105.1 million | $192.3 million | $392.1 million |
| Net income available to common stockholders | $91.4 million | $102.3 million | $187.2 million | $381.3 million |
| Diluted EPS | $0.37 | $0.43 | $0.78 | $1.60 |
| Nareit FFO | $161.0 million | $159.1 million | $462.3 million | $490.4 million |
| Cash flow from operating activities | Not separately reported | Not separately reported | $452.8 million | $472.0 million |
Q3 2023 net margin was approximately 38.8%, compared with 43.9% in Q3 2022. The nine-month net margin was approximately 27.1%, compared with 53.5% in the prior-year period. These comparisons were materially affected by impairments, asset-sale gains and operator collectibility issues.
- Q3 rental income increased 1.1% to $209.9 million, while nine-month rental income declined 2.8% to $618.1 million.
- Q3 interest income declined 2.3% to $30.6 million; nine-month interest income declined 6.0% to $88.3 million, principally because certain operator loans were placed on non-accrual or PIK arrangements.
- Q3 impairment expense increased to $27.9 million from $10.0 million. Nine-month impairment expense increased to $88.0 million from $21.2 million.
- Q3 gain on asset sales was $44.1 million, compared with $40.9 million. Nine-month gain on asset sales fell to $70.0 million from $179.7 million.
- Allowance and provision for credit losses was $11.6 million for the nine months, compared with $4.4 million in 2022. The allowance for credit losses totaled $188.3 million at September 30, 2023.
Balance Sheet, Debt and Liquidity
- Total assets were $9.4 billion and total equity was $3.9 billion at September 30, 2023.
- Total debt was $5.3 billion, representing approximately 58.0% of total capitalization. The weighted average debt interest rate was 4.3%, compared with 4.1% at December 31, 2022.
- Approximately 99% of debt with outstanding principal balances had fixed interest payments.
- Cash and cash equivalents were $554.7 million, or $557.9 million including restricted cash, versus $300.6 million at December 31, 2022.
- Availability under the revolving credit facility was approximately $1.4 billion. The company reported compliance with applicable debt covenants.
- Omega repaid $350 million of senior notes that matured in August 2023 using available cash and entered into a $428.5 million 2025 term loan commitment, including a $28.5 million accordion increase. Interest-rate swaps effectively fixed the term loan rate at approximately 5.597% through maturity.
- The company had $400 million of 4.95% senior notes due in April 2024. Management stated that cash, revolver availability, operating cash flow and remaining ATM capacity provide flexibility to address this maturity.
Cash Flow and Capital Allocation
| Cash flow category | 9M 2023 | 9M 2022 |
|---|---|---|
| Operating activities | $452.8 million | $472.0 million |
| Investing activities | $(112.1) million | $272.4 million |
| Financing activities | $(83.5) million | $(627.5) million |
| Increase in cash, cash equivalents and restricted cash | $257.3 million | $113.8 million |
- The company acquired 26 facilities for $210.0 million during the first nine months and sold 37 facilities for $261.3 million of net cash proceeds.
- It funded $52.4 million of construction and capital improvements, $129.1 million of new or existing real estate loans and $108.1 million of new or existing non-real estate loans.
- Common dividends paid were $479.3 million, and the quarterly dividend remained $0.67 per share.
- Equity issuance under the ATM program and dividend reinvestment plan generated $330.2 million of gross proceeds during the nine months. No shares were repurchased.
Material Changes Versus the Prior Comparable Period
- Net income available to common stockholders declined 10.7% in Q3 and 50.9% for the nine months, while Nareit FFO increased 1.2% in Q3 but declined 5.7% year to date.
- Revenue trends were pressured by lower cash collections and the absence of straight-line rental income from operators on a cash basis, particularly Maplewood and LaVie.
- Impairments rose substantially as Omega exited or restructured relationships involving non-strategic facilities and operators.
- Asset-sale gains were substantially lower year to date because the prior-year period included significant Gulf Coast-related dispositions.
- Four cash-basis operator portfolios covering 48 facilities were transitioned to five operators recognized on a straight-line basis. Nevertheless, 18 operators remained on a cash basis, representing 25.1% of nine-month revenues excluding write-offs.
- Omega completed significant operator restructurings. Agemo resumed contractual payments but remains on non-accrual accounting; Maplewood continued monthly rent shortfalls; LaVie made a $13.3 million Q3 short payment; and Guardian missed August and September contractual payments.
Outlook, Risks, Contingencies and Unusual Items
Management expects available liquidity sources to fund expected needs over the next twelve months, including dividends, debt service, investments, loan advances and recurring corporate expenses. The filing does not provide formal earnings or FFO guidance.
- Operators continue to face labor shortages, elevated staffing costs, occupancy challenges, inflation and uncertainty regarding Medicare and Medicaid reimbursement.
- The expiration of the federal COVID-19 public health emergency on May 11, 2023 ended or reduced certain waivers and reimbursement support. The phase-out of enhanced Medicaid FMAP support may pressure operator cash flows.
- CMS proposed minimum staffing requirements for nursing homes. Management stated that the timing, final scope and availability of funding remain uncertain and that unfunded requirements could adversely affect operators.
- Operator concentration remains material. CommuniCare generated approximately 10.9% of nine-month revenues and represented approximately 9.0% of total investments. Maplewood represented 7.2% of nine-month revenues; LaVie represented 4.3%.
- Real estate loans and non-real estate loans had net balances of $1.1 billion and $245.0 million, respectively, with significant reserves related to Agemo, LaVie and other financially challenged borrowers.
- Remaining commitments totaled approximately $294.1 million, including $194.0 million of lease construction and capital commitments, $51.0 million of other real estate loan commitments and $43.1 million of non-real estate loan commitments.
- The company disclosed proposed settlements of shareholder derivative actions, subject to formal documentation and court approval. A separate dispute concerning Gulf Coast subordinated debt remained stayed in Delaware while related Maryland litigation was on appeal.
- Subsequent to quarter end, Omega sold 29 LaVie facilities in November 2023 for $305.2 million of purchase consideration and reduced LaVie’s monthly rent to $3.4 million. The company also acquired one Maryland facility and funded mortgage and mezzanine loans for two Pennsylvania facilities.
Most Important Facts for Investors to Verify
- Whether operator cash collections, rent shortfalls and restructuring activity improve, particularly for Maplewood, LaVie, Guardian and Agemo.
- The amount and timing of the April 2024 senior-note refinancing or repayment and the company’s liquidity after that transaction.
- Future impairment charges, credit-loss provisions and recoveries on the $1.4 billion combined real estate and non-real estate loan portfolio.
- The sustainability of the $0.67 quarterly dividend relative to recurring cash flow and Nareit FFO.
- The final scope, timing and funding of CMS staffing requirements and their effect on operator profitability and rent-paying capacity.
- The effect of the November 2023 LaVie disposition and rent reduction on future rental revenue, debt balances and asset concentration.
- The company’s ability to execute planned dispositions, transitions and capital commitments without further material losses.